“…The publication date of the included studies ranged from 1992 to 2019. Ten studies were conducted in Europe, 19,25,[27][28][29][30]32,33,35,37 seven in North America 5,12,24,26,34,36,38 and two in the Middle East 3,20 ( Table 1). Among the seven case-control studies, five were matched on age and sex, 19,24,27,29,32 one on respiratory function, 39 and one on cystic fibrosis transmembrane conductance regulator (CFTR) mutation.…”